abstract |
Compounds of Formula X: wherein A, X, Y, Z, R, R, and R are as defined herein, and pharmaceutically acceptable salts thereof, are described as useful for the treatment of cognitive deficits associated with schizophrenia and other neurodegenerative and/or neurological disorders in mammals, including humans. |